Materials and methods

Cell culture
HeLa cells were grown in DMEM supplemented with 10% FCS, 0.2 mM L-glutamine, 100 units/ml penicillin and 100 g/ml streptomycin (all Sigma) and were plated on 12-well plates containing an 18 mm diameter coverslip for immunofluorescence microscopy (IFM), or on 145-mm tissue culture dishes (Greiner bio-one) for subsequent protein purification. For synchronization prior to IFM studies, cells were treated with 2 mM thymidine for 24 hr, released for 6 hr, and then treated with 10 µM Taxol (Paclitacxel, Sigma) for 4 hr. For the last 100 min the proteasome inhibitor MG132 (Sigma) was added at 10 µM final concentration.
To obtain mitotic cells which were arrested in the presence of an active (on) or inhibited (off) spindle checkpoint, cells were incubated without or with 100 nM of the Aurora B inhibitor Hesperadin (Boehringer-Ingelheim, Vienna) for the last 60 min, respectively. Alternatively, following the 6 hr release cells were incubated for 4 hr with 50 ng/ml Nocodazole (Sigma).
Nocodazole was washed out and cells were incubated for 2 hr with MG132 alone or MG132 plus 100 ng/ml Nocodazole. For synchronization prior to protein purification, cells were initially arrested by incubating them either with 10 µM Taxol or with 50 ng/ml Nocodazole for 14 hr. Subsequently, cells were treated as described in the synchronization protocol for IFM analysis. For the cytospin-IFM experiments cells were synchronized as for protein purification.
Immunofluorescence microscopy
Cells were fixed with 4% formaldehyde in PBS at room temperature on coverslips or after spinning them onto slides by Cytospin (Shandon Brand). After fixation samples were permeabilized with 0.5% Trition-X100 in PBS for 15 min and thereafter blocked with 10% FCS in PBS containing 0.01% Triton-X100. Samples were incubated for 1 hr each at room temperature with primary and secondary antibodies and mounted with ProLong Gold (Molecular Probes). Images were taken on a Zeiss Axioplan 2 microscope using a 100x PlanApochromat objective lenses (Carl Zeiss, Jena) equipped with a CoolSnapHQ CCD camera (Photometrics).
Antibodies were used at the following dilutions: human Crest (Cortex Biochem) 1:1000; mouse anti-cyclin-B (GNS1, Santa Cruz Biotechnology) 1:500, rabbit anti-Mad2 (Covance) 1:500; mouse anti-Bub1 (MBL International) 1:500; rabbit anti-BubR1 (see below) 1:1000.
Alexa 488, Alexa 568 and Alexa 633 labeled secondary antibodies as well as DAPI were from Molecular Probes (Invitrogen).
Image processing and quantification
Images were acquired as raw 12- Cyclin-B levels were measured as average cytoplasmic intensity.
Immunoprecipitation experiments
Antibodies raised against pApc1 (phosphorylated S355), Apc2, Cdc27, Apc4, Apc5, Apc7, Cdh1 and Cdc20 were described previously (2) (3) (4) (5) (6) insect cells. Preparation of cell extracts and immunoprecipitation (IP) using antibodies crosslinked to beads (Affi-prep protein A beads, BioRad) were described elsewhere (7).
Re-immunoprecipitation (reIP) experiments
APC/C was affinity-purified from HeLa cells arrested with an active checkpoint using Cdc27
antibody-crosslinked beads. The native complex was eluted with 2 bead volumes of 1 mg/ml antigenic peptide dissolved in IP buffer (20 mM Tris-HCl pH7.5, 150 mM KCl, 10% glycerol, 0.1% Tween and 0.5 mM DTT). Two subpopulations of APC/C were separated by consecutive reIP. 3 volumes of APC/C peptide eluate were incubated first with 1 volume of BubR1, Cdc20 or Mad2 antibody coupled beads and second with anti-Apc4 beads. Beads were washed 3 times by resuspending them in 20 bead volumes of IP buffer for 5 min at 4°C
and APC/C was recovered by elution with the antigenic peptides or 100 mM glycine-HCl at pH 2.2.
Cdc20 and Cdh1 were bound to the mix of both APC/C species immobilized on Cdc27 beads by incubating them with 3.6, 1.8 or 0.9 µM of either of the coactivators in IP buffer. 2 bead volumes of coactivator dilution were mixed with 1 volume APC/C beads on a rotary shaker for 30 min at room temperature. The excess of coactivator was removed by washing the beads 4 times with 50 volumes IP buffer prior to peptide elution and separation of the two APC/C populations by reIP. His 6 -tagged Cdc20 and Cdh1 were expressed in Baculovirus-infected Sf9 insect cells (8) .
Mass spectrometry
Tryptic peptides were loaded onto the trap column at a flow rate of 20 µL/min with mobile phase A (5% acetonitrile, 0.1% formic acid) and were washed for 10 min. The sample was eluted from the trap column and separated on the separation column with a gradient from 0% to 50% mobile phase B (80% acetonitrile, 0.08% formic acid) in 30 min at a flow rate of 300 nL/min. Eluting peptides were ionized with a spray voltage set to 1.5 kV. CAD fragmentation and spectra acquisition were carried out in the linear ion trap using a data dependent neutral loss MS³ method. Acquired data (Xcalibur RAW-file) was converted into Sequest DTA-files using the program extract_msn, part of Sequest Bioworks Browser (version 3.2 -Thermo Electron), and further merged into Mascot generic files using Mascot Daemon (Matrix Science). For peptide identification a database search against a custom database containing all relevant proteins was performed using Mascot (Matrix Science; version 2.2.0).
All nano-HPLC separations were performed using UltiMate 3000 Nano-LC system (Dionex Benelux) equipped with a trap column (PepMap C18, 300 µm). Mass spectrometric analyses were conducted on a hybrid linear ion trap / Fourier transform ion cyclotron resonance (FTICR) mass spectrometer (LTQ-FT Ultra, ThermoElectron). The mass spectrometer was equipped with a nano-electrospray ionization source (Proxeon Biosystems). Metal coated nano ESI needles were used (New Objective).
In vitro ubiquitylation assay
To measure the ubiquitylation activity of immunopurified APC/C, 1-3 µl APC/C bound antibody beads were used in XB buffer (10 mM Hepes-KOH, pH 7.7, 100 mM KCl, 2 mM MgCl 2 , 0.1 mM CaCl 2 and 1 mM DTT) containing purified E1 (0.5 µM), UbcH10 (8.2 µM), ubiquitin (0.3 mM), ATP regenerating system (7.5 mM creatine phosphate, 1 mM ATP, 1 mM MgCl 2 , 0.1 mM EGTA, 30 U/ml rabbit creatine phosphokinase type I (Sigma)). Human
His-E1 and His-UbcH10 were expressed in E.coli and purified on a Ni-NTA resin (8) . To charge UbcH10 with ubiquitin before addition of APC/C and substrate, E1, UbcH10, ubiquitin and ATP were preincubated at 36°C for 5 min. The substrate, an iodinated human cyclin-B1 fragment (amino acid residues 1-87, 3.5 µM) and APC/C bound beads were incubated with the reaction mix in a total volume of 10 µl at 36°C and 1200 rpm in a thermomixer (Eppendorf). The reaction was stopped by the addition of 4 x SDS sample buffer. The radiolabel of the substrate protein allowed detection by SDS-PAGE and autoradiography and the quantification of substrate-ubiquitin conjugates over time was performed with ImageJ (http://rsb.info.nih.gov/ij/).
Full length human cyclin-A2, cyclin-B1, securin and Nek2A were generated by coupled transcription/translation in rabbit reticulocyte lysates (TNT, Invitrogen). APC/C bound antibody beads were incubated with 10 µl reaction mix containing 2-3.5 µl of IVT-substrate, 5 µM MG132 and 2.3 µM ubiquitin aldehyde (Sigma).
Preparation of APC/C for electron microscopy APC/C was isolated on Cdc27 antibody beads from lysates of HeLa cells (7) . Bound protein was washed four times with 50 bead volumes of TBS (20 mM Tris-HCl, pH 7.6, 150 mM NaCl and 0.5 mM DTT). APC/C was eluted with TBS containing 1 mg/ml Cdc27 peptide for 15 minutes at 4°C. The excess of peptide was removed and APC/C particles were stabilized by applying the APC/C peptide eluate onto a glycerol density gradient containing glutaraldehyde. This procedure is called GraFix and was described by Kastner et al. (9) .
Negative staining electron microscopy at low temperatures
Purified APC/C or APC/C-antibody complexes were adsorbed to a thin film of carbon and then transferred to an electron microscopic grid covered with a perforated carbon film. The bound APC/C particles were stained with 2% uranyl formate, blotted and air dried for ~1 min at room temperature. For negative staining at low temperatures ( 
Unstained cryo-electron microscopy
GraFix peak fractions were subjected to desalting spin columns (Zeba spin columns, Pierce)
to remove glycerol. APC/C was bound to a thin layer of carbon and flash frozen into liquid ethane (11) . Images were recorded using the same procedure and the same microscope as described for negative staining at low temperatures. We have used unstained cryo-EM and negative staining EM for 3D structure determination of apo-APC/C ( fig. S5 ) as well as APC/C MCC ( Fig. 2C ).
Processing of electron microscopy images
Particle images (200 x 200 pixel) were selected using the semi-automated software boxer as part of the Eman package. Images were coarsened by a factor of two resulting in 100 x 100 pixels per image with a sampling of ~3.8 Å/pixel. After CTF correction (12), images were aligned using an exhaustive multi-reference alignment based on resampling to polar coordinates (13) . Characteristic views were obtained by averaging after multivariate statistical analysis and classification (14) . Angular reconstitution (15) was used to determine the relative orientations of the projection images prior to computing the 3D reconstruction.
We have performed supervised classification based on projection matching to separate apo-APC/C from APC/C MCC or APC/C Cdc20 complexes. Projection matching was also used to separate the three different conformations that we found for the apo-APC/C complex.
Initially, these three different conformations were obtained by the random conical tilt reconstruction technique (16) . 3D structures were visualized with the software AmiraDev 2.3
(TGS Europe, Merignac Cedex).
Localization of APC/C subunits and the coactivators Cdc20 and Cdh1 by negative staining EM
Loading of recombinant Cdc20 and Cdh1 in vitro
N-terminally His 6 -tagged human Cdc20 and Cdh1 were expressed in Baculovirus-infected Sf9 cells and purified via the His-tag (8) . Apo-APC/C was purified from HeLa cells arrested with an active checkpoint by Cdc27-IP followed by consecutive reIP as described. Apo-APC/C bound to beads was incubated with ~0.5-1.0 µM recombinant Cdc20 or Cdh1 for 30 min at 4°C. Beads were washed three times with 50 volumes of TBS and eluted with the antigenic peptide. In case of Cdh1, experiments were also performed in parallel with APC/C isolated from Xenopus interphase egg extracts (7).
Antibody labeling
Peptide eluted human APC/C preparations were incubated with decreasing concentrations of pApc1, Cdc27, Apc4, Apc5, Cdc16, Apc7 and BubR1 antibodies starting at a molar APC/C to IgG ratio of 2:1. At the antibody concentration yielding a high percentage of APC/C dimers, samples were processed using the GraFix protocol and analyzed by negative staining EM.
The concentration of particles on the EM grid was chosen to be very low to ensure that APC/C dimers were not formed accidentally by the presence of large amounts of APC/Cs.
200-300 APC/C dimers were selected for each antibody labeling experiment to determine the antibody binding sites. First the projection direction of each APC/C monomer was determined and a rectangular plane was drawn in 3D, perpendicular to the imaging plane at the antibody binding site. The x,y dimensions of the rectangular planes reflect the uncertainties of detecting the binding site of the antibody ( fig S8) . However, in case of Apc1, Cdc27, Apc4, Apc5 and
BubR1 labeling experiments the rectangular planes did precisely intersect in 3D describing a single spot on the surface of APC/C. We were thus able to determine the location of APC/C subunits at an accuracy that is reflected by the size of the spheres shown in Fig. 3A . In case of Apc7 and Cdc16 the labeling was considerably less accurate, possibly due to the presence of multiple copies of these subunits. Single labeling spots were not obtained in those cases.
However, both proteins were found to be located in the "arc lamp" domain of APC/C.
Random conical tilt 3D reconstruction
The recently published 3D structure of the fission yeast APC/C (17) has mirrored handedness with respect to the Xenopus APC/C 3D structure determined by Dube et al. (18) . We have therefore repeated the random conical tilt experiment of negatively stained human apo-APC/C to solve the handedness problem. 8859 tilted image pairs were collected in negative stain and 350 random conical tilt 3D reconstructions were computed. Individual RCT 3D models were aligned by an automated exhaustive 3D alignment via polar coordinates combined with a weighted averaging procedure (19). The entire procedure was first tested with a 70S E. coli ribosome data set to make sure that the obtained handedness is correct. We have obtained a well defined consensus 3D structure of human APC/C ( fig. S5 ) which unambiguously confirms the handedness that we have determined for Xenopus APC/C (18). In addition to providing the APC/C structure with correct handedness, the set of aligned RCT 3D
reconstructions was subjected to three-dimensional multivariate statistical analysis and classification to analyse the structural variation within one single data set. Using this unsupervised classification procedure, three distinct structures of the apo-APC/C were obtained that differ in their relative orientation of the two major APC/C domains. The obtained structures were subsequently refined using standard projection matching techniques ( Fig. 2A , apo-APC/C).
Crosslinking of UbcH10
UbcH10 was covalently linked to the heterobifunctional crosslinker Sulfo-GMBS (N- mg/ml BSA for 1 hr (Fig. 4A) . The beads were washed 3 times with buffer A and mixed with 80 µl of APC/C eluate for 1 hr at RT. Subsequently, the excess of soluble APC/C was removed, beads were washed 3 times with buffer B (50 mM Tris-HCl, pH7.5, 150 mM NaCl, 0.5% Tween, 5 mM EDTA) and bound proteins were eluted with 30 µl 2 x SDS sample buffer containing 5 mg/ml BSA.
Conversely, 15 µl samples of APC/C bound beads were incubated with various dilutions of wild type or D-box mutant cyclin-B (Fig.4B) , wild type securin (Fig. 4C) 
Supplementary Figures
Figure S1 Unless indicated otherwise, APC/C structures presented in this paper were obtained using negative staining EM at low temperatures. Stabilization of APC/C during GraFix allowed us to remove glycerol from the gradient fractions and to perform also unstained cryo-imaging of APC/C embedded in vitrified buffer. The 3D reconstructions obtained by both techniques for apo-APC/C (shown here) and for APC/C MCC (Fig. 2C) are very similar. The resolution obtained for the unstained cryo-EM reconstructions is considerably lower than the resolution obtained by negative staining at low temperatures (table S2) . This can be attributed to the final buffer exchange step which is important to remove glycerol for unstained cryo-EM but which has significantly affected the integrity of APC/C particles. Focusing the electron beam on a small area reveals a bright spot in the center due to water evaporation. As a control, the grid was allowed to warm up to RT inside the microscope and then the test was repeated on an adjacent area. In this case (representing normal negative stain conditions at room temperature) no water was evaporated after focusing the beam at an increased magnification for 30 seconds. These observations indicate that APC/C molecules are still hydrated when using negative staining at low temperatures in contrast to conventional negative staining. In parallel to the Cdc20 labeling experiments, recombinant Cdh1 was bound to human apo-APC/C and analyzed by negative staining EM (left panel). We identified a single protein mass bound in a position that is similar to the position of Cdc20 in human APC/C Cdc20 (Fig. 2B) . In contrast to this situation, we had previously observed two extra densities in the Xenopus APC/C structure following binding of recombinant Cdh1 (18) . However, only the position on the right side was previously interpreted as a Cdh1 binding site because only this site could be confirmed by Cdh1 antibody labeling experiments (18) . We therefore re-analyzed the Xenopus APC/C Cdh1 complex using the new GraFix sample preparation protocol (9) which led to a 3D reconstruction of significantly higher quality (right panel). The new Xenopus APC/C Cdh1 3D reconstruction shows again two extra densities, one on the right hand side, and one in a central position where Cdh1 can also be seen in human APC/C. It is therefore possible that APC/C contains more than one Cdh1 binding site. Which of these sites is functionally more important, and why two sites can only be detected in Xenopous APC/C will require further investigation. Movie S1. The movie shows an animated morphing scene between different populations of apo-APC/C that were found to be present in one single sample. It is important to note that the transition between the different populations is just an animation to illustrate the major structural differences, namely a different relative orientation of the "platform" and "arc lamp"
domain.
3D-pdf S1 and 3D-pdf S2. The 3D-pdf files S1 and S2 display 3D models of human apo-APC/C and APC/C MCC , respectively. The MCC protein mass of APC/C MCC is coloured in red visualizing the contacts formed between MCC and APC/C (Adobe Reader 9).
